Revelstoke Capital Partners has expanded its senior investment team with the addition of Eric Shuey as Managing Director. Mr. Shuey will be responsible for new investment sourcing, transaction execution and portfolio management.
“We are very excited to have Eric join Revelstoke as a Managing Director. He has the rare blend of a strong track record in both direct investing and successfully managing and operating businesses. We look forward to him delivering that expertise and judgment to our existing and future portfolio of companies,” said Simon Bachleda, Managing Partner at Revelstoke.
Mr. Shuey has more than 25 years of private equity investing, corporate finance and executive management experience in the healthcare industry. He previously served as a senior executive at Fresenius Medical Care where he was involved with several strategic initiatives including $1.5 billion of corporate investments and acquisitions. Prior to Fresenius, Mr. Shuey was a member of the senior management team of Liberty Dialysis (a Bain Capital portfolio company) which grew Liberty from a $10 million revenue business into the third largest national provider of dialysis services with over $1 billion of revenue and operating more than 260 clinics in 32 states. Liberty was sold to Fresenius Medical Care in early 2012 for over $2.3 billion. Earlier in his career, Mr. Shuey served as a Director at DB Capital Partners, the private equity arm of Deutsche Bank responsible for over $10 billion in assets, and a Principal at Aurora Capital Group, a $1 billion private equity firm. Mr. Shuey started his investment banking career as an associate in DLJ’s Los Angeles office.
“I’ve been fortunate to have had the opportunity to work with and invest alongside Eric across numerous companies over the last decade, and I look forward to working closely with him to build value in our existing portfolio companies and identify new and exciting investment opportunities,” said Russell Cassella, a Managing Partner at Revelstoke.
Mr. Shuey has an MBA from the Wharton School of Business. In addition, he has completed the coursework for a PhD in Management at the Wharton School and earned his BA from California State University Fullerton.
“I am thrilled to have the opportunity to join Revelstoke Capital Partners. Revelstoke has established itself as a leading healthcare and business services private equity firm, and I am looking forward to being a key contributor to the firm’s future growth,” said Mr. Shuey.
Revelstoke invests from $10 million to $250 million in companies that have at least $5 million of EBITDA. Sectors of interest include healthcare services and products; transportation and logistics; specialty distribution; energy and energy services; building products; business and outsourced services; marketing services; financial services; industrial services; and medical technology. Revelstoke has $1 billion of assets under management, and since the firm’s inception in mid-2013, has completed 34 acquisitions, which includes 9 platform companies and 25 add-on acquisitions. The firm is headquartered in Denver (www.revelstokecp.com).
© 2017 Private Equity Professional | October 23, 2017